Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Dermatol Res ; 308(5): 357-65, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27098388

ABSTRACT

The potential role of oncogenic viruses mediating development of proliferative skin lesions in patients treated with RAF inhibitors is poorly understood. The objective of this study was to investigate human papilloma virus (HPV) and Merkel cell polyomavirus (MCPyV) in skin lesions among patients treated with RAF inhibitors with the help of a case series describing prevalence of HPV, MCPyV, and RAS mutations in skin biopsies obtained from patients receiving RAF inhibitors and developing cutaneous lesions. HPV-DNA was amplified by PCR utilizing multiple nested primer systems designed for detection of a broad range of HPV types. MCPyV copy number determination with real time PCR technology was performed by a "Quantification of MCPyV, small t region" kit. Thirty-six patients were tested (squamous cell carcinoma (SCC) = 14; verruca vulgaris = 15; other = 11). Nine of 12 SCCs (75 %) and eight of 13 verruca vulgaris lesions (62 %) tested positive for MCPyV whereas none of the normal skin biopsies obtained from nine of these patients tested positive for MCPyV (p = 0.0007). HPV incidence in cutaneous SCCs was not different compared to normal skin (50 vs. 56 %, p = 0.86). The association between MCPyV and proliferative skin lesions after RAF inhibitor therapy merits further investigation.


Subject(s)
Carcinoma, Squamous Cell/virology , Imidazoles/adverse effects , Melanoma/drug therapy , Merkel cell polyomavirus/isolation & purification , Oximes/adverse effects , Papillomaviridae/isolation & purification , Protein Kinase Inhibitors/adverse effects , Proto-Oncogene Proteins B-raf/antagonists & inhibitors , Skin Neoplasms/virology , Warts/virology , Adult , Aged , Aged, 80 and over , Biopsy , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/pathology , Female , Humans , Imidazoles/therapeutic use , Male , Melanoma/genetics , Middle Aged , Mutation , Oximes/therapeutic use , Prospective Studies , Protein Kinase Inhibitors/therapeutic use , Proto-Oncogene Proteins B-raf/genetics , Retrospective Studies , Skin/pathology , Skin Neoplasms/drug therapy , Skin Neoplasms/pathology , Warts/chemically induced , Warts/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...